Dyspnea treatment

Respiratory Care

Volumn 45, Issue 11, 2000, Pages 1342-1351

  Manning, H L ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Acupuncture; Benzodiazepines; Chest wall vibration; Chronic obstructive pulmonary disease; COPD; Dyspnea; Lung cancer; Palliative care

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BICARBONATE; BUPIVACAINE; BUSPIRONE; CLORAZEPATE; CODEINE; CORTICOSTEROID; DEXTROMETHORPHAN; DIAMORPHINE; DIAZEPAM; DIHYDROCODEINE; INDOMETACIN; LIDOCAINE; MORPHINE; OPIATE; PHENOTHIAZINE DERIVATIVE;

ACUPUNCTURE; BLOOD TRANSFUSION; CHEMORECEPTOR; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG INDUCED DISEASE; DYSPNEA; HERBAL MEDICINE; HUMAN; LUNG CANCER; NEBULIZATION; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHYSIOTHERAPY; SENSORY STIMULATION; VAGOTOMY;

ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; COMPLEMENTARY THERAPIES; DYSPNEA; HUMANS; PALLIATIVE CARE; RESPIRATORY MECHANICS; RESPIRATORY THERAPY; TERMINAL CARE;

EID: 0034554815     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (51)

1. Distinguishable types of dyspnea in patients with shortness of breath
2. Respiratory mechanics in airways obstruction associated with inspiratory dyspnoea
3. CO2 in mechanically ventilated quadriplegics
4. CO2 persists after complete neuromuscular block in humans
5. Breathlessness and respiratory mechanics during reflex or voluntary hyperventilation in patients with chronic airflow limitation
6. Dyspnoea: Assessment and pharmacological manipulation
7. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases
8. Breathlessness, alcohol, and opiates
9. Dihydrocodeine for breathlessness in "pink puffers"
10. Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction
11. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease
12. Oral diamorphine: Lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome
13. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease
14. Effects of morphine on the dyspnea of terminal cancer patients
15. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial
16. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer
17. Subcutaneous morphine for dyspnea in cancer patients
18. Expression of opioid peptides in tumors
19. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease
20. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease
21. Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient
22. Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease
23. Disabling dyspnoea in patients with advanced disease: Lack of effect of nebulized morphine
24. Nebulized morphine in the palliation of dyspnoea
25. Diazepam in the treatment of dyspnoea in the 'Pink Puffer' syndrome
26. Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: A case study
27. Drug treatment of breathlessness: Contrasting effects of diazepam and promethazine in pink puffers
28. Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction
29. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease
30. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease
31. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease
32. Sertraline effects on dyspnea in patients with obstructive airways disease
33. The effect of indomethacin on breathlessness in patients with diffuse parenchymal disease of the lung
34. Indomethacin and perception of dyspnea in chronic airflow obstruction
35. Lack of effect of dextromethorphan on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease (COPD)
36. Effects of induced metabolic alkalosis on perception of dyspnea during flow-resistive loading
37. Effects of small-particle aerosols of local anaesthetic on dyspnoea in patients with respiratory disease
38. Ventilation and breathlessness on maximal exercise in patients with interstitial lung disease after local anaesthetic aerosol inhalation
39. Safety and efficacy of nebulized lignocaine in patients with cancer and breathlessness
40. Does cold air affect exercise capacity and dyspnea in stable chronic obstructive pulmonary disease?
41. Blood transfusion and its benefits in palliative care
42. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease
43. Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease
44. In-phase chest wall vibration decreases dyspnea during arm elevation in chronic obstructive pulmonary disease patients
45. Experimental results of vagal block in cardiopulmonary disease
46. A study of the effects of unilateral vagus nerve block in a dyspnoeic patient
47. Extreme dyspnea from unilateral pulmonary venous obstruction: Demonstration of a vagal mechanism and relief by right vagotomy
48. Controlled trial of acupuncture for disabling breathlessness
49. Acupuncture for the relief of cancer-related breathlessness
50. Acupressure as an adjunct to a pulmonary rehabilitation program
51. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms